Laennec Bioscience Private Limited

Laennec Bioscience Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U24231TN2004PTC053667 Incorporated 07 July 2004 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2024
₹64.3 Lakh
▲ 153% YoY
Net profit · FY 2024
₹72,211
Net margin 1.1%
EBITDA · FY 2024
₹1.21 Lakh
EBITDA margin 1.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
22 yrs
Est. 2004
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered

About Laennec Bioscience Private Limited

Data last updated:

Laennec Bioscience Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 July 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN2004PTC053667. Its GSTIN is 32AABCL1267G1ZW (Kerala).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sreekumar (Managing Director) and Vaibhav Sreekumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 82 II Floor Audiapa Naickenstreet Sowcarpet Chennai 79 Street Sowcarpet Chennai 79, Tamil Nadu, India – 600079.

As per the financials filed for FY 2024, the company reported a revenue of ₹64.3 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹72,211 (net margin 1.1%) and EBITDA of ₹1.21 Lakh (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 44% over three years and 42% over five years.

Laennec Bioscience Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-08-0017775). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24231TN2004PTC053667
Registration Number 053667
Incorporation Date 07 July 2004
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KL-08-0017775

Recognitions & Rankings of Laennec Bioscience

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-KL-08-0017775

Contact details

Laennec Bioscience Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.

  • Email
  • Registered Address
    82 II Floor Audiapa Naickenstreet Sowcarpet Chennai 79 Street Sowcarpet Chennai 79, Tamil Nadu, India – 600079
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Laennec Bioscience Private Limited, buy the company report.

Comprehensive company report
Laennec Bioscience Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Laennec Bioscience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Laennec Bioscience Private Limited, buy the company report.

Financials of Laennec Bioscience Private Limited

FY 2025 filings available

Laennec Bioscience Private Limited reported revenue of ₹64.3 Lakh (up 153% YoY) for FY 2024.

Revenue · FY 2024
₹64.3 Lakh ▲ 153%
Net profit · FY 2024
₹72,211 margin 1.1%
EBITDA · FY 2024
₹1.21 Lakh margin 1.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 153%
3 years · compounded
▲ 44%
5 years · compounded
▲ 42%
EBITDA CAGR growth
1 year
▼ 15%
3 years · compounded
▼ 36%
5 years · compounded
▲ 21%

Revenue has grown at a compounded annual rate (CAGR) of 42% over five years, including 153% growth in the latest year. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.21 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹72,211
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin1.9%
Net Profit Margin1.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Laennec Bioscience Private Limited, buy the company report.

Board of directors of Laennec Bioscience Private Limited

Laennec Bioscience has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Vaibhav SreekumarDirector14 Mar 20179 Years 7 MonthsCurrent
SreekumarManaging Director07 Jul 200422 Years 3 MonthsCurrent
Vaishnav M SreekumarDirector15 Nov 20169 Years 11 MonthsCurrent
ShinyDirector15 Nov 20169 Years 11 MonthsCurrent

Auditor

Laennec Bioscience Private Limited is audited by PAVITHRAN & MURALI for the financial year 2018.

Auditor firmFinancial yearFirm registration number
PAVITHRAN & MURALIFY 2018002622S

Shareholding

The shareholding of Laennec Bioscience Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2018FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Laennec Bioscience Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Laennec Bioscience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Laennec Bioscience has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
32AABCL1267G1ZWKeralaActive01 Jul 2017

To see the full GST registrations and return filing status of Laennec Bioscience Private Limited, buy the company report.

Recent activity

Laennec Bioscience Private Limited has 10 board changes on record since 2004: 4 appointments and 6 cessations. The latest: Shiny ceased to be Additional Director on 30 Sep 2017.

AGM
Laennec Bioscience Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Laennec Bioscience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Ceased
Shiny ceased to be Additional Director.
Ceased
Sreekumar ceased to be Director.
Ceased
Vaibhav Sreekumar ceased to be Additional Director.
Ceased
Vaishnav M Sreekumar ceased to be Additional Director.
Appointed
Vaibhav Sreekumar was appointed as Director.
Ceased
Hassan Anantharam Nataraja ceased to be Director.
Ceased
Sanjay Arattil Poovadan ceased to be Managing Director.
Appointed
Shiny was appointed as Director.
Appointed
Vaishnav M Sreekumar was appointed as Director.
Appointed
Sreekumar was appointed as Managing Director.

1 earlier event is in the company report.

Frequently asked questions

Laennec Bioscience is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 July 2004 (22+ years old) and is registered under CIN U24231TN2004PTC053667.

Laennec Bioscience has 4 current directors:

The latest financial statements of Laennec Bioscience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Laennec Bioscience is 32AABCL1267G1ZW, registered in Kerala.

The CIN (Corporate Identification Number) of Laennec Bioscience is U24231TN2004PTC053667. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Laennec Bioscience was incorporated on 07 July 2004, making it 22+ years old. It is registered with the Registrar of Companies, Chennai.

Shiny ceased to be Additional Director on 30 Sep 2017. Sreekumar ceased to be Director on 30 Sep 2017. Vaibhav Sreekumar ceased to be Additional Director on 30 Sep 2017. Laennec Bioscience has 10 board changes on record in total.

Yes, Laennec Bioscience is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-08-0017775).

The registered office of Laennec Bioscience is at 82 II Floor Audiapa Naickenstreet Sowcarpet Chennai 79 Street Sowcarpet Chennai 79, Tamil Nadu, India – 600079.

Laennec Bioscience operates in the pharma industry, in the drug formulation and development segment.